| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2009 | CN100518744C A bacterium-resisting nursing article |
| 07/29/2009 | CN100518743C Compound digoxin preparation for treating chronic heart failure |
| 07/29/2009 | CN100518742C Triterpene compounds which are effective on improvement of brain function |
| 07/29/2009 | CN100518741C Pregnane steroids for use in the treatment of cns dysfunction |
| 07/29/2009 | CN100518740C Use of heterocyclic compounds as SCCE inhibitors |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/29/2009 | CN100518738C Self-assembly precursor liposome containing camptothecine medicine, and its preparing method |
| 07/29/2009 | CN100518737C Cilostazol solid agent |
| 07/29/2009 | CN100518736C Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/29/2009 | CN100518734C Medicine composition containing bailobalide |
| 07/29/2009 | CN100518733C Compositions for the treatment and prevention of diabetes mellitus |
| 07/29/2009 | CN100518732C A process for the preparation of ferutinine from ferula genus plants |
| 07/29/2009 | CN100518731C Use of phenoxyacetic acid derivatives for treating hyperactive bladder |
| 07/29/2009 | CN100518730C Novel Subing drop pills and preparation method |
| 07/29/2009 | CN100518729C Liquor for increasing cow born ratio and its manufacturing method |
| 07/29/2009 | CN100518728C Medicament for preventing and treating bacterial disease of domestic silkworm and preparation process thereof |
| 07/29/2009 | CN100518727C Preparaton method of anticancer medicine colchicin microsphere freeze dried agent |
| 07/29/2009 | CN100518726C Pharmaceutical solutions of modafinil compounds |
| 07/29/2009 | CN100518725C Venlafaxine hydrochloride liquid slow-release preparation and its preparation method |
| 07/29/2009 | CN100518718C Preparation of powder agglomerates |
| 07/29/2009 | CN100518531C Method of removing caffeine from caffeine-containing catechin compound composition |
| 07/29/2009 | CA2619367A1 Gel preparation for oral administration |
| 07/28/2009 | US7566805 Modafinil compositions |
| 07/28/2009 | US7566803 Vitamin D receptor modulators |
| 07/28/2009 | US7566791 Substituted 3-carbonyl-1h-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 07/28/2009 | US7566789 2-[2-(5-chlorothiophen-2-yl)-1H-benzimidazol-5-yl]-N-[4-(3-oxomorpholin-4-yl)phenyl]acetamide; anticoagulants of blood factor Xa; treating thromboembolic diseases, thrombosis; antitumor agent for treating of tumours |
| 07/28/2009 | US7566785 Amidine substituted aryl aniline compounds |
| 07/28/2009 | US7566784 Bicyclic heterocycles as kinase inhibitors |
| 07/28/2009 | US7566782 Process for the preparation of rosuvastatin |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566778 Central nervous system disorders; psychological disorders |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566741 Methods of inhibiting osteoclast activity |
| 07/28/2009 | US7566740 Method of treating mucositis |
| 07/28/2009 | US7566739 analgesic activity for treating pain, migraine, neuralgia, fibromyalgia; nontoxic, good absorption, good half-life, good solubility, low protein binding affinity, side effect reduction; 2-(4-tert-butyl-3,5-difluorophenoxy)-N-(1-{3-methyl-4-[(methylsulfonyl) amino]phenyl}ethyl)acetamide |
| 07/28/2009 | US7566738 3-aminopropylsulfinic acid analogs; antispasmodic; gastroesophageal reflux disease; addiction; cough; GABA B receptor agonists; well absorbed in the large intestine and/or colon and hence suitable for oral sustained release formulations |
| 07/28/2009 | US7566737 antioxidants and PPAR activators; with rosiglitazone, irbesartan, ezetimibe, simvastatin, Fenofibrate; inflammation, neurodegeneration, cell proliferation; restenosis, atherosclerosis, type 2 diabetes, obesity, hypertension; 1-[2-hydroxy-4-chlorophenyl]-3-[4-carboxydimethylmethyloxyphenyl]prop-2-en-1-one |
| 07/28/2009 | US7566736 Substituted indoles, compositions containing them, method for the production thereof and their use |
| 07/28/2009 | US7566735 Compounds which potentiate AMPA receptor and uses thereof in medicine |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566733 Benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 07/28/2009 | US7566732 5-(1H-benzimidazol-2-ylmethylene)-3-(4-fluorophenyl)-2-thioxo-1,3-thiazolidin-4-one; ubiquitin ligase (synthetase) inhibitors; inhibit ubiquitination of target proteins; poxviruses; herpesviruses; retroviruses; variola viruses; smallpox; hemorrhagic smallpox; HIV; vaccines; side effect reduction |
| 07/28/2009 | US7566731 2-(Chloro),4-(ethoxycarbonyl-isoprop-2,2-ylene-isoprop-2,2-ylene-oxycarbonyl-methyl),5-(methyl-thiazole; bactericides; herbicides; insecticides; fungicides; nematocides; algicides; molluscicides; construction materials; wood; clay; alkali resistance |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/28/2009 | US7566729 doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage |
| 07/28/2009 | US7566728 Advance circadian rhythm disorders; using opioid receptor antagonist |
| 07/28/2009 | US7566727 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor |
| 07/28/2009 | US7566726 3-Trifluoromethyl,6-((3-(methyl,4-hydroxytetrahydropyran-4-yl)-amino-(3-isopropyl-cyclopent-1,3-ylene))-carbonyl-)-5,6,7,8-tetrahydro-1,6-naphthyridine; antiinflammatory agents; immunomodulators; antiallergens; rhintis; dermatitis; conjunctivits, asthma; autoimmune diseases; antiarthritis agents |
| 07/28/2009 | US7566725 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics |
| 07/28/2009 | US7566724 Glycine derivative and use thereof |
| 07/28/2009 | US7566723 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use |
| 07/28/2009 | US7566722 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists |
| 07/28/2009 | US7566721 Substituted thienol[2,3-d]pyrimidines as kinase inhibitors |
| 07/28/2009 | US7566720 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 07/28/2009 | US7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 07/28/2009 | US7566718 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 07/28/2009 | US7566717 Substituted heterocyclic compounds |
| 07/28/2009 | US7566716 Imidazopyrazines as Raf inhibitor compounds |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | US7566714 Methods and compositions for the treatment of metabolic disorders |
| 07/28/2009 | US7566713 Immuno inhibitory heterocyclic compounds |
| 07/28/2009 | US7566712 Biaryl piperazinyl-pyridine analogues |
| 07/28/2009 | US7566711 Dimethylcarbamic acid 4-(2-allyl,1-benzylcarbamoyl,8-(2,4-difluorobenzyl)-4,7-dioxo-octahydropyrazino(2,1-c)(1,2,4)triazin-6-yl)methylphen-4-yl ester; combinatorial libraries; anticarcinogenic agents; colorectal cancer; cell growth regulation; antiproliferiative/-apoptosis agents; Wnt transcription |
| 07/28/2009 | US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 07/28/2009 | US7566709 4-(3-(2-Fluorophenyl)-1-phenyl-1H-pyrazol-4-ylmethyl)morpholine; 5HT2A/5HT2C receptors; central nervous system; schizophrenia; antidepressants; dementia; Parkinson's disease; Azheimer's disease; Huntington's disease; Tourette's syndrome; anxiolytic agents; congnition activators; analgesics |
| 07/28/2009 | US7566708 Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/28/2009 | US7566705 Combination of formoterol and mometasone furoate for asthma |
| 07/28/2009 | US7566704 anti-infective to combat infection associated with burns, surgery, chemotherapy, bone marrow disorders and other conditions in which the immune system may be compromised; high molecular weight determined by multi-angle laser light scattering (VHMW-glucan) |
| 07/28/2009 | US7566703 represents phosphodiester or phosphodiester-like internucleotide linkage; for treating allergy, such as allergic rhinitis and asthma, cancer and hepatitis B and hepatitis C infectious diseases |
| 07/28/2009 | US7566702 Immunostimulatory oligonucleotide multimers |
| 07/28/2009 | US7566700 siRNA molecules which target the transcription factor STAT6 and repress the expression of STAT6 mRNA, STAT6 protein and STAT6 function in lung cells |
| 07/28/2009 | US7566699 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/28/2009 | US7566698 Extracted from plants such as Ningxia Lycium barbarum L. and/or Lycium chinense Mill; glucosyltransferases, cellulases; provitamin C with improved stability and bioavailability; ultraviolet damage protector; antiwrinkling; whitening |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566546 Modulators of angiogenesis and tumorigenesis |
| 07/28/2009 | US7566535 Enhanced oligonucleotide-mediated nucleic acid sequence alteration |
| 07/28/2009 | US7566495 Using blend of styrene polymer and polyurethane |
| 07/28/2009 | US7566470 Grain fractionation methods and products |
| 07/28/2009 | US7566464 Cosmetic composition to accelerate repair of functional wrinkles |
| 07/28/2009 | US7566463 Improved via addition of sweetener, increase in potassium content, and/or by increase in citric acid content |
| 07/28/2009 | US7566460 Hand lotion and surgical scrub; alcohol, chlorhexidine salt, and emulsifier |
| 07/28/2009 | US7566458 Influenza hemagglutinin and neuraminidase variants |
| 07/28/2009 | US7566454 Immunization against influenza by administering codon-optimized forms of nucleic acids encoding influenza polypeptides such as influenza hemagglutinin (HA), neuraminidase (NA) |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | US7566452 Treating cancer using antagonists to the endothelin B receptor (ETB) or inactive mimic forms of endothelin-1; melanoma |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | CA2542292C Triterpene compounds which are effective on improvement of brain function |
| 07/28/2009 | CA2505964C Pharmaceutical compositions and dosage forms of thalidomide |
| 07/28/2009 | CA2472008C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/28/2009 | CA2470747C Extended release pharmaceutical tablet of metformin |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/28/2009 | CA2447329C 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/28/2009 | CA2443012C Use of pyridoindolone derivatives for preparing medicines |
| 07/28/2009 | CA2433591C Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 07/28/2009 | CA2413883C Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
| 07/28/2009 | CA2411406C Manipulation of oxidative phosphorylation for hypersensitizing tumor cells to glycolytic inhibitors |
| 07/28/2009 | CA2408541C Treating eczema and/or psoriasis |
| 07/28/2009 | CA2408537C Treating irritable bowel syndrome or disease |